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Abstract 1 
 2 In the human genome, most genes undergo splicing and patterns of codon usage 3 are splicing-dependent: guanine and cytosine (GC) content is highest within 4 single-exon genes and within first exons of multi-exon genes.  However, the 5 effects of codon usage on gene expression are typically characterized in 6 unspliced model genes.  Here, we measured the effects of splicing on expression 7 in a panel of synonymous reporter genes that varied in nucleotide composition. 8 We found that high GC content increased protein yield, mRNA yield, cytoplasmic 9 mRNA localization and translation of unspliced reporters. Splicing did not affect 10 the expression of GC-rich variants.  However, splicing promoted the expression 11 of AT-rich variants by increasing their steady-state protein and mRNA levels, in 12 part through promoting cytoplasmic localization of mRNA. We propose that 13 splicing promotes the nuclear export of AU-rich mRNAs and that codon- and 14 splicing-dependent effects on expression are under evolutionary pressure in the 15 human genome. 16   17 
 3 
Introduction 18  19 Mammalian genomes are characterised by large regional variation in base 20 composition (Bernardi, 1993). Regions with a high density of G and C nucleotides 21 (GC-rich regions) are in an open, transcriptionally active state, are gene-dense, 22 and replicate early. In contrast, AT-rich regions are enriched with 23 heterochromatin, contain large gene deserts and replicate late (Arhondakis et al., 24 2011; Lander et al., 2001; Vinogradov, 2003). The mechanisms that give rise to 25 this compositional heterogeneity have been under debate for years and many 26 researchers believe that the pattern originates from the process of GC-biased 27 gene conversion (Duret and Galtier, 2009), though other neutral and selective 28 mechanisms have been proposed as well (Eyre-Walker, 1991; Galtier et al., 2018; 29 Plotkin and Kudla, 2011; Sharp and Li, 1987b). 30  31 The sequence composition of mammalian genes correlates with the GC-content 32 of their genomic location. Thus, introns and exons of genes located in GC-rich 33 parts of the genome are themselves GC-rich. This can potentially influence gene 34 expression in multiple ways: nucleotide composition affects the physical 35 properties of DNA, the thermodynamic stability of RNA folding, the propensity of 36 RNA to interact with other RNAs and proteins, the codon adaptation of mRNA to 37 tRNA pools, and the propensity for RNA modifications, such as m6A (Dominissini 38 et al., 2012) and ac4C (Arango et al., 2018). However, studies of the effects of 39 nucleotide composition on gene expression in human cells have led to opposing 40 conclusions. On the one hand, heterologous expression experiments typically 41 report large positive effects of increased GC content on protein production in a 42 wide variety of transgenes, including fluorescent reporter genes, human cDNAs, 43 and virus genes (Bauer et al., 2010; Kosovac et al., 2011; Kotsopoulou et al., 44 2000; Kudla et al., 2006; Zolotukhin et al., 1996). As a result, increasing the GC 45 content of transgenes has become a common strategy in coding sequence 46 optimization for heterologous expression in human cells (Fath et al., 2011). On 47 the other hand, genome-wide analyses of endogenous genes typically show little 48 or no correlation of GC content with expression (Duan et al., 2013; Lercher et al., 49 2003; Rudolph et al., 2016; Semon et al., 2005).  50 
 4 
 51 We hypothesized that the conflicting results in heterologous and endogenous 52 gene expression studies might be explained by RNA splicing. Most transgenes 53 used in heterologous expression systems have no introns, whereas 97% of genes 54 in the human genome contain one or more introns. Splicing is known to influence 55 gene expression at multiple stages, including nuclear RNP assembly, RNA export, 56 and translation. If splicing selectively increased the expression of AT-rich genes, 57 it could account for the lack of correlation of GC content and gene expression in 58 previous genome-wide studies. We therefore compared spliced and unspliced 59 genes with respect to their (1) genomic codon usage, (2) expression levels of 60 reporter genes in transient and stable transfection experiments and (3) global 61 expression patterns in human transcriptome studies. We show that splicing 62 increases the expression of AT-rich genes, but not GC-rich genes, in part through 63 effects on cytoplasmic RNA enrichment.  64  65 
Results 66 
 67 
Codon usage of human protein-coding genes depends on RNA splicing 68 We first analysed the relationship between the nucleotide composition of human 69 genes and splicing. GC4 content (guanine and cytosine content at 4-fold 70 degenerate sites of codons) correlates negatively with the number of exons in 71 humans (Figure 1A; Spearman’s ρ = −0.27; p < 2.2u10-16; see also (Carels and 72 Bernardi, 2000; Ressayre et al., 2015; Savisaar and Hurst, 2016)). In addition, 73 GC4 content is highest in 5'-proximal exons (Figure 1B; Spearman’s ρ = −0.18; p 74 < 2.2u10-16), and first exons have a higher GC4 content than second exons (p < 75 2.2u10-16, one-tailed Wilcoxon test). Although these patterns could result from 76 proximity to GC-rich transcription start sites (TSSs) (Zhang et al., 2004), we 77 found that first exons have significantly higher GC4 content than second exons 78 even when controlling for the distance from the TSS (Figure 1C). This suggests 79 that splicing contributes to the observed enrichment of G and C nucleotides in 80 the 5'-proximal exons in humans. Interestingly, there is little association 81 between exon counts and GC content among human lncRNAs (Figure S1). 82  83 
 5 
To understand the causal links between splicing and nucleotide composition, we 84 studied the compositional patterns of retrogenes. Retrotransposition provides a 85 natural evolutionary experiment of what happens when a previously spliced 86 gene suddenly loses its introns. We first analysed a set of 49 parent-retrogene 87 pairs for which both the parent and the retrocopy ORFs have been retained in 88 human and mouse. We found that the retrocopies had a significantly higher GC4 89 content than their parents (median GC4retrocopy - GC4parent = 11.5%; p = 2.1u10-4 90 from one-tailed Wilcoxon test; Figure 1D). It thus appears that after 91 retrotransposition, newly integrated intronless genes come under selective 92 pressure for increased GC content. In a comparison of 31 parent-retrogene pairs 93 retained between human and macaque, the median GC4 difference is not 94 significant (0.09%; p = 0.13, Wilcoxon test), but this may be explained by 95 duplication events in macaques being more recent (dS ~ 0.08) than in mouse (dS 96 ~ 0.56) (Gradnigo et al., 2016; Ponting and Goodstadt, 2009) so that changes in 97 GC composition might not have had time to accumulate. As a control, we 98 analysed retrocopies classified as pseudogenes (Figure S1D) and found their GC4 99 content to be significantly lower compared to their parental genes (-2.9%; p < 100 2.2u10-16, Wilcoxon test). Furthermore, the genomic neighbourhood of 101 functional retrocopies and pseudogenes had significantly lower GC content than 102 the neighbourhood of their respective parental genes (Figure S1E), suggesting 103 that increased GC content is not intrinsically connected with retrotransposition, 104 but is required for maintaining long-term functionality of retrogenes. Taken 105 together, these results support a splicing-dependent mechanism shaping 106 conserved patterns of nucleotide composition across functional protein-coding 107 genes. 108  109 
GC-content is a strong predictor of expression of unspliced reporter genes 110 The above analyses show a connection between splicing and genomic GC content 111 of endogenous human genes. To test whether splicing differentially affects the 112 expression of genes depending on their GC content, we designed 22 synonymous 113 variants of GFP that span a broad range of GC3 content (GC content at the third 114 positions of codons) (Mittal et al., 2018) (Figure S2). The collection encompasses 115 most of the variation in GC3 content found among human genes. All variants 116 
 6 
were independently designed by randomly drawing each codon from an 117 appropriate probability distribution, to ensure uniform GC content and statistical 118 independence between sequences. We cloned these variants into two 119 mammalian expression vectors: an intronless vector with a CMV promoter 120 (pCM3) and a version of the same vector with a synthetic intron located in the 5' 121 UTR (pCM4). The GC content profiles of the 5’ UTRs were similar in both vectors 122 (Figure S2E,F), and the intron was spliced efficiently in all variants tested, 123 independently of the coding sequence GC content (Figure S3A). The vectors also 124 encoded a far-red fluorescent protein, mKate2, which we used to normalize GFP 125 protein abundance (normalization reduced measurement noise, but similar 126 results were obtained with and without normalization). Transient transfections 127 of HeLa cells with three independent preparations of each plasmid showed 128 reproducible expression with a large dynamic range: synonymous variants 129 differed in GFP protein production 46-fold. Consistent with previous studies, GFP 130 fluorescence was strongly correlated with GC3 content in unspliced genes 131 (Figure 2A). Introduction of an intron into the 5' UTR increased the expression of 132 most, but not all variants. Typically, GC-poor variants experienced a large 133 increase of expression in the presence of an intron, whereas GC-rich variants 134 were unaffected or experienced a moderate increase (Figure 2B,C). 135  136 We obtained similar results in stably transfected HEK293 and HeLa cells (Figure 137 S3B,C) and when expressing an independently designed collection of 25 138 synonymous variants of mKate2 in HeLa cells (Figure 2D-F). A Fisher's exact test 139 revealed that the expression of GC-poor variants was more likely to be increased 140 by splicing, compared to GC-rich variants (GC3<60% vs GC3>60%, p=0.02, N=47, 141 GFP and mKate variants combined). These experiments show that many AT-rich 142 genetic variants are expressed inefficiently in human cells, but low expression 143 can be partially rescued by splicing. Notably, the average GC content of the 144 human genome is 41% (Li, 2011). In our experiments, genes with GC content at 145 or below 41% are expressed extremely inefficiently, unless they contain an 146 intron (Figure 2A,B). This may provide a strong selective pressure for 147 maintaining introns in human genes. 148  149 
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To establish which stages of expression are responsible for these observations, 150 we first measured mRNA abundance of GFP variants in transiently transfected 151 HeLa cells by quantitative RT-PCR (qRT-PCR). High GC content may introduce 152 unwanted bias in PCR, so to allow fair comparison of all variants irrespective of 153 their GC content, PCR primers were placed in the untranslated regions, whose 154 sequence did not vary. Similar to protein levels, mRNA abundance varied widely 155 between synonymous variants of GFP. GC-poor variants experienced a large 156 increase of expression in the presence of an intron, whereas GC-rich variants 157 were less affected (Figure 2G-I). The range of variation in mRNA abundance was 158 much smaller in constructs with an intron than without intron (Figure 2I), 159 indicating that splicing compensates the effects of GC content on expression. 160  161 We then asked if changes in mRNA abundance arose at transcriptional or post-162 transcriptional levels. As a proxy for transcriptional efficiency, we measured the 163 abundance of intronic RNA for GFP variants expressed from the intron-164 containing plasmid. Coding sequence GC content did not correlate with intronic 165 RNA abundance (Figure 2J), suggesting that transcription of the 5' UTR intron 166 does not depend on GC content of the coding sequence. We further performed 167 metabolic labelling of nascent RNA using 4-thiouridine (4sU) in cell lines stably 168 expressing GC-poor and GC-rich GFP variants, expressed both with and without 169 
5’ UTR intron, followed by nascent RNA purification and qRT-PCR (Figure 170 S3D,E). We did not observe any systematic variation in nascent GFP RNA levels 171 that could be explained by either GC content or splicing. Conversely, high GC 172 content was associated with stabilization in unspliced and spliced constructs 173 (Figure 2K). Taken together, these experiments show that high GC content 174 enhances gene expression at a post-transcriptional level, and that the effect of GC 175 content on expression is modulated by splicing. 176  177 
High GC content at the 5’ end correlates with efficient expression 178 To further explore the sequence determinants of expression, we assembled a 179 pool of 217 synonymous variants of GFP that included the 22 variants studied 180 above, 137 variants from our earlier study (Kudla et al., 2009), and 58 additional 181 variants. We cloned the collection into plasmids with and without a 5' UTR 182 
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intron. We then established pools of HeLa Flp-In T-REx cells that stably express 183 these constructs from a single genomic locus under a doxycycline-inducible 184 promoter and measured the protein levels of all variants by Flow-Seq (Kosuri et 185 al., 2013). We also performed Flow-Seq in HEK293 cells using the intronless 186 constructs only. In Flow-Seq, a pool of cells is sorted by FACS into bins of 187 increasing fluorescence and the distribution of variants in each bin is probed by 188 amplicon sequencing to quantify protein abundance (Figure 3A). All variants 189 could be quantified with good technical and biological reproducibility, and high 190 correlation was found between Flow-Seq and spectrofluorometric measurement 191 of individual constructs (Figure S4). Most variants showed the expected 192 unimodal distribution across fluorescence bins, but some variants showed 193 bimodal distributions, possibly indicative of gene silencing in a fraction of cells. 194  195 All Flow-Seq experiments showed substantial variation of expression between 196 synonymous variants of GFP (Figure 3B). GFP protein levels in HeLa cells (with 197 intron), HeLa cells (without intron), and HEK293 cells (without intron) were all 198 correlated with each other, but the moderate degree of correlation (r=0.51 199 HEK293 (without intron) vs HeLa (without intron); r=0.36 Hela (with intron) vs 200 HeLa (without intron)) suggests that the effects of codon usage on expression 201 are modulated by splicing and by cell line identity - in agreement with prior 202 observations of tissue-specific codon usage (Burow et al., 2018; Gingold et al., 203 2014; Plotkin et al., 2004; Rudolph et al., 2016). Flow-Seq confirms the positive 204 correlation of synonymous site GC-content with expression of unspliced variants, 205 whereas no significant correlation was found among intron-containing variants 206 (Figure 3C). In contrast to results reported by us and others in bacteria and yeast 207 (Cambray et al., 2018; Goodman et al., 2013; Kudla et al., 2009; Shah et al., 2013), 208 but consistently with the positive correlation between GC content and 209 expression, strong mRNA folding near the beginning of the coding sequence 210 correlated with increased expression (Spearman’s ρ = 0.27 in HeLa cells; ρ = 0.4 211 in HEK293 cells). Expression was positively correlated with CpG content and 212 codon adaptation index (CAI), and negatively correlated with the estimated 213 density of AU-rich elements (ARE) or cryptic splice sites (see STAR methods for 214 definitions of all sequence features tested). Because of the strong correlation 215 
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between GC content, CpG content, CAI and mRNA folding energy, a multiple 216 regression analysis could not resolve which of these properties was causally 217 related to expression.  218  219 Some of the variants analysed by Flow-Seq featured large regional variation in 220 GC content (Figure S5A) and we asked whether the localization of low-GC and 221 high-GC regions within the coding sequence influences expression. We found 222 that the GC3 content in the first half of the coding sequence (nt 1-360), but not in 223 the second half (nt 361-720), was positively correlated with expression of 224 intronless GFP variants in the HeLa and HEK293 cells (Figure 3D). The GC3 225 content in either half of the gene showed no correlation with expression in the 226 intron-containing constructs. 227  228 To further test whether GC content at the 5' end of genes has a particularly 229 important effect on expression, we constructed in-frame fusions between GC-230 rich and GC-poor variants of GFP and mKate2 genes and quantified their protein 231 and mRNA abundance in transient transfection experiments. RNA and protein 232 yields showed a dependence on the GC content profile: GC-poor mKate2 showed 233 nearly undetectable expression on its own, or when fused to the 5' end of GC-rich 234 GFP, but it was efficiently expressed when fused to the 3' end of GC-rich GFP 235 (Figure 3E, left panels). Similarly, expression of GC-poor GFP was significantly 236 enhanced when it was fused to the 3' end of GC-rich mKate2 (Figure 3E, right 237 panels). By contrast, pairs of GC-rich variants were efficiently expressed when 238 fused in either orientation. N-terminal fusion of GC-rich GFP had a slightly larger 239 positive effect on expression compared to GC-rich mKate, perhaps because of 240 differences in codon usage or protein folding. Taken together, these experiments 241 confirm that GC content near the 5' end of the coding sequence has a large effect 242 on expression.  243  244 
Introns within the coding sequence enhance GC-poor gene expression 245 While the experiments described above utilised an intron placed in the 5’ UTR, it 246 should be noted that most introns within human genes are found within the CDS. 247 To examine the relationship between intron location and gene expression 248 
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changes relating to codon usage, we modified two GFP variants by moving their 249 introns from the 5' UTR into the coding sequence (Figure 3F). We chose variants 250 that were AT-rich (GC3=0.38 and 0.37), poorly expressed (HeLa Flow-Seq scores 251 3.71 and 4.4.) and experienced a large increase in expression when expressed 252 with a 5’ UTR intron (HeLa Flow-seq scores 6.18 and 5.98). Transient 253 transfections confirmed the positive effect of a 5’ UTR intron on expression of 254 both variants (Figure 3F, first 2 bars in each plot). When the intron was placed 255 within the coding sequence, expression was also increased compared to the 256 intronless counterparts, suggesting that the positive effects of splicing on 257 expression are not inherently linked to the intron position. For one of the 258 variants, the inclusion of both 5’ UTR and CDS introns led to a further increase in 259 expression. This is consistent with our genome-wide observation that codon 260 usage is linked to number of introns. Taken together, these results support a 261 splicing-dependent effect of codon usage on gene expression. 262  263 
High GC content leads to cytoplasmic enrichment of mRNA and higher 264 
ribosome association 265 We then used the pooled HeLa cell lines to analyse the effects of GC content on 266 mRNA localization. We separated the cells into nuclear and cytoplasmic 267 fractions, isolated RNA and performed amplicon sequencing of each fraction to 268 analyse mRNA localization of each GFP variant. Analysis of fractions showed the 269 expected enrichment of the lncRNA MALAT1 in the nucleus, and of tRNA in the 270 cytoplasm, confirming the quality of fractionations (Figure 4A). For each GFP 271 variant, we calculated the relative cytoplasmic concentration of its mRNA (RCC) 272 as the ratio of cytoplasmic read counts to the sum of reads from both fractions 273 (RCC = c_cyto / (c_cyto+c_nuc); Figure 4B). A value of 0 therefore indicates 100% 274 nuclear retention, whereas a value of 1 indicates 100% cytoplasmic localization. 275 In the absence of splicing, RCC scores ranged from 0.09 to 0.64 and RCC 276 correlated significantly with GC content (r=0.51, p=3.85u10-13, Figure 4C). In the 277 presence of a 5’ UTR intron, we observed a significant increase in RCC score for 278 GFP variants with low GC content, but no increase in RCC for GC-rich variants 279 (Figure 4D). GC3 content at the beginning of the coding sequence was 280 significantly correlated with RCC in the absence of splicing (r=0.5, p=2.0u10-11), 281 
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but not in the presence of splicing (r<0.01, p=0.48; Figure S5B).  Thus, high GC 282 content at the 5' end of genes increases gene expression in part through 283 facilitating the cytoplasmic localization of mRNA.  284  285 To assess whether GC content also affects translational dynamics, we performed 286 polysome profiling on HEK293 GFP pool cells using sucrose gradient 287 fractionation (Figure 5A). qRT-PCR analysis of RNA extracted from all collected 288 fractions showed a broad distribution of GFP across fractions, with enrichment 289 within polysome-associated fractions. In order to determine distribution 290 patterns of individual GFP variants, RNA from several fractions was pooled (as 291 indicated in Figure 5B) and subjected to high-throughput sequencing. The 292 resulting read distribution indicates that GC-rich variants are associated with 293 denser polysomal fractions (ribosome density, Figure 5C, left panel; R2=0.55, p < 294 2.2u10-16) and are more likely to be translated (ribosome association, Figure 5C, 295 right panel; R2=0.28, p<9.03u10-15), compared to GC-poor variants. This suggests 296 that enhanced translational dynamics also contribute to more efficient 297 expression of GC-rich genes. 298  299 
The expression fate of endogenous RNA depends on splicing, nucleotide 300 
composition, and cell type 301 To test whether splicing- and position-dependent effects of codon usage can be 302 observed among human genes, we turned to genome-wide measurements of 303 expression at endogenous human loci and related these measurements to codon 304 usage and splicing. Although the correlations between GC content and 305 expression depended on the experimental measure and type of cells under study, 306 we find that GC4 content usually has a more positive effect on gene expression in 307 unspliced genes relative to spliced ones (Figure 6, Table S1). In particular, 308 unspliced mRNAs show a more positive/less negative correlation of GC4 with 309 transcription initiation (GRO-cap data); cytoplasmic stability (exosome mutant); 310 RNA (whole cell RNA-seq); cytoplasmic enrichment (cell fractionation), 311 translation rate (ribosome profiling vs whole cell RNA-seq); and protein amount 312 (mass-spec). These analyses suggest that GC4 content has an effect on the RNA 313 abundance of intronless mRNA molecules, which is carried through to the 314 
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protein expression. Taken together, these genome-wide analyses support our 315 observation of a splicing-dependent relationship between codon usage and 316 expression in human cells. 317  318 
Discussion 319 
 320 We have shown that the effects of GC content on gene expression in human cells 321 are splicing-dependent (the effect is larger in unspliced genes compared to 322 spliced genes) and position-dependent (the effect is larger at the 5’ end of genes 323 than at the 3’ end). In addition, human genes show striking patterns of codon 324 usage, which differ between spliced and unspliced genes and between first and 325 subsequent exons. Our results have implications for the understanding of the 326 evolution of human genes and the functional consequences of synonymous 327 codon usage. 328 
 329 
Mechanisms of splicing- and position-dependent effects of codon usage 330 Specific patterns of codon usage have previously been found at the 5’ ends of 331 genes in bacteria, yeast and other species (Gu et al., 2010; Kudla et al., 2009; 332 Tuller et al., 2010). In bacteria and yeast, strong mRNA folding near the start 333 codon prevents ribosome binding and reduces translation efficiency, resulting in 334 
selection against strongly folded 5’ mRNA regions (Kudla et al., 2009; Shah et al., 335 2013). In addition a “ramp” of rare codons has been observed near the 5’ end of 336 RNAs in multiple species, with a possible role in preventing a wasteful 337 accumulation of ribosomes on mRNAs (Tuller et al., 2010) or reducing the 338 strength of mRNA folding (Bentele et al., 2013). These phenomena cannot 339 explain our results in human, because both the folding energy and codon ramp 340 models predict low GC content near the start codon, whereas we observe high GC 341 content within first exons of human protein-coding genes (Figure 1B). 342 Furthermore, our experiments show that high GC content near the start codon 343 increases expression, whereas the folding energy and codon ramp models would 344 predict low expression. 345  346 
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We propose instead that splicing- and position-dependent effects of GC content 347 are explained by early post-transcriptional events in the lifetime of an mRNA. 348 Using matched reporter gene libraries, we show that most, but not all, variants 349 show an increase in expression when spliced. Splicing typically increases the 350 expression of AT-rich variants, but it does not further increase the expression of 351 GC-rich transcripts, which suggests that splicing and high GC content influence 352 expression through at least one common mechanism. Splicing increases 353 transcription (Kwek et al., 2002), prevents nuclear degradation (Nott et al., 354 2003), facilitates nuclear-cytoplasmic mRNA export through the Aly/REF-TREX 355 pathway (Muller-McNicoll et al., 2016), and stimulates translation (Nott et al., 356 2004). High GC content might increase RNA polymerase processivity (Bauer et 357 al., 2010; Zhou et al., 2016); AT-rich genes are more likely to contain cryptic 358 polyadenylation sites (consensus sequence: AAUAAA) (Higgs et al., 1983; Zhou et 359 al., 2018) or destabilizing AU-Rich Elements (AREs); and AU-rich mRNAs may be 360 preferentially localized in P-bodies (Courel et al., 2019) or in the nucleus (this 361 study). GC-rich sequence elements of endogenous unspliced genes were 362 previously shown to route transcripts into the splicing-independent ALREX 363 nuclear export pathway, allowing efficient cytoplasmic accumulation (Palazzo et 364 al., 2007). In agreement with this, low expression caused by inhibitory sequence 365 features (such as low GC-content) can be rescued by extending the mRNA at the 366 
5’end with a GC-rich sequence (Figure 3E). This may act as a compensatory 367 mechanism when gene expression cannot rely on the positive regulatory effects 368 of splicing (Palazzo and Akef, 2012). In contrast, it was recently shown that 369 binding of HNRNPK to the GC-rich SIRLOIN motif leads to nuclear enrichment of 370 lncRNAs (and also some mRNAs) (Lubelsky and Ulitsky, 2018). Our genomic 371 analyses of lncRNA sequences do not show the same splicing-dependent 372 compositional patterns as observed in mRNAs and it is therefore likely that 373 antagonistic pathways act simultaneously in shaping the RNA expression 374 landscape. Thus, we propose that the genomic patterns and their consequences 375 on gene expression reported here are general features of protein-coding genes. 376  377 Recent studies highlight patterns of codon usage as major determinants of RNA 378 stability in yeast (Presnyak et al., 2015), zebrafish (Mishima and Tomari, 2016) 379 
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and other species (Bazzini et al., 2016). The usage of less common, ‘non-optimal’ 380 codons within transcripts was shown to control poly-A tail length and RNA half-381 life in a translation-dependent manner through the coupled activity of different 382 CCR4-NOT nucleases (Radhakrishnan et al., 2016; Webster et al., 2018). 383 Consistent with these findings, we observed that CAI is positively correlated with 384 mRNA expression levels in human cells. However, it remains to be seen whether 385 the correlation of CAI with mRNA expression depends on translation. Because of 386 the strong correlation between GC content and CAI, it is difficult to disentangle 387 independent contributions of these variables. Additionally, we find that the 388 correlation between GC content (or CAI) and expression is position- and splicing-389 dependent, whereas no evidence for such context-dependence has been reported 390 for the CCR4-NOT-mediated mechanism.  391  392 Other instances in which the effects of codon usage are context-dependent have 393 been described. Most notably, tRNA populations and transcriptome codon usage 394 patterns were shown to differ between mammalian tissues (Dittmar et al., 2006; 395 Gingold et al., 2014; Plotkin et al., 2004; Rudolph et al., 2016). Intriguingly, genes 396 preferentially expressed in proliferating cells and tissue-specific genes tend to be 397 AT-rich, whereas genes expressed in differentiated cell types and housekeeping 398 genes are more GC-rich (Gingold et al., 2014; Vinogradov, 2003). Although these 399 differences have been interpreted in terms of the match between codon usage 400 and cellular tRNA pools, it is plausible that translation-independent mechanisms 401 contribute to context-dependent effects of codon usage. Accordingly, in 402 Drosophila, codon optimality determines mRNA stability in whole cell embryos, 403 but not in the nervous system, independent of tRNA abundance (Burow et al., 404 2018). Recently, it was shown that Zinc-finger Antiviral Protein (ZAP) selectively 405 recognises high CpG-containing viral transcripts as a mechanism to distinguish 406 self from non-self (Takata et al., 2017). We speculate that similar regulatory 407 proteins and mechanisms exist for cellular expressed genes. The cell lines used 408 in the present study, HeLa and HEK293, are both rapidly proliferating and 409 experimental results are correlated (r=0.36, Flow-Seq data), but divergent 410 expression of some GFP variants was also observed. Similarly, the effect size of 411 GC content on the expression of endogenously expressed genes varies with cell 412 
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type. It would be interesting to compare the expression of our variants in other 413 cell types to further address the question of tissue-specific codon usage and 414 adaptation to tRNA pools. 415 
 416 
Implications for the evolution of protein-coding genes 417 The fact that long, multi-exon genes are often found in GC-poor regions of the 418 genome might result from regional mutation bias, but an alternative explanation 419 is possible: GC-poor genes may be under selective pressure to retain their 420 introns, and intronless genes may experience selective pressure to increase their 421 GC content. These alternative explanations are supported by multiple 422 observations: Firstly, endogenous intronless genes are on average more GC-rich 423 than intron-containing genes. Secondly, the GC content of functional (but not 424 non-functional) retrogenes is higher compared to their respective intron-425 containing parental genes, which cannot be explained by a systematic integration 426 bias. Thirdly, in genome-wide analysis, correlations between GC-content and 427 expression are generally more positive (or less negative) for unspliced compared 428 to spliced genes. Taken together, this suggests that for the long-term success of 429 an unspliced gene (i.e. stable conservation of expression and functionality) an 430 increase in GC content is essential. By contrast, splicing allows genes to remain 431 functional even when mutation bias or other mechanisms lead to a decrease of 432 their GC content.  433 
 16 
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Figure 1. Splicing- and position-dependent patterns of nucleotide 456 
composition in human genes. 457 (A) GC4 distribution of human protein-coding genes, grouped by number of 458 exons per gene. The Y axis indicates the proportion of genes within a given range 459 of GC4. 460 (B) Mean GC4 content in protein-coding exons, grouped by exon position (rank) 461 and by number of exons per gene. 462 (C) Mean GC4 for individual codons within exons of rank 1 (black dots) or rank 2 463 (white dots) downstream of the transcription start site (TSS). 464 (D) GC4 distribution of functional retrogenes (dark grey) and their 465 corresponding parental genes (light grey) conserved between mouse and human 466 
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(p=2.1u10-4, from one-tailed Wilcoxon signed rank test, n=49). See also Figure 467 S1. 468 
 469 
Figure 2. The effect of GC content on gene expression depends on splicing. 470 (A-B) Protein levels of 22 GFP variants when transiently expressed as unspliced 471 (A) or spliced (B) constructs in HeLa cells and quantified by spectrofluorometry. 472 Each data point represents the mean of 9 replicates, +/- SEM. GFP Relative 473 Fluorescence Units (RFU) are defined as (GFP fluorescence - background GFP 474 fluorescence)/(mKate fluorescence - background mKate fluorescence), where 475 background fluorescence was measured in mock-transfected cells. 476 (C) Correlation of protein levels between unspliced and spliced variants of GFP 477 (n=22, R2=0.69, p=9.0u10-7). The dashed line indicates x=y.  478 (D-E) Protein levels of 23 mKate2 variants in the absence (D) or presence (E) of 479 splicing. Each data point represents the mean of 9 replicates, +/- SEM. mKate 480 RFU are defined as (mKate fluorescence - background mKate fluorescence), 481 where background fluorescence was measured in mock-transfected cells. 482 (F) Correlation of protein levels between unspliced and spliced variants of 483 mKate2 (n=23, R2=0.29, p=2.8u10-4). 484 (G-H) mRNA levels of 10 GFP variants when transiently expressed as unspliced 485 (G) or spliced (H) constructs in HeLa cells and quantified by qRT-PCR. Data 486 points represent the mean of 3 replicates, +/- SEM, calculated as (GFP 487 RNA)/(NeoR RNA). 488 (I) Comparison of mRNA expression from spliced and unspliced GFP variants 489 (n=10, R2=0.49, p=0.014). 490 (J) Intronic RNA levels of GFP variants measured by qRT-PCR, calculated as (GFP 491 intronic RNA)/(NeoR RNA). 492 (K) RNA stability time course of 6 GFP variants expressed from stably 493 transfected HEK293 Flp-in cells after blocking transcription with 500 nM 494 triptolide. Variants were expressed as unspliced and spliced constructs. Results 495 represent the averages of 2 independent experiments. RNA stability of c-myc 496 (n=12) and GAPDH (n=6) are shown as unstable and stable RNA controls. See 497 also Figures S2 and S3. 498  499 
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Figure 3. Splicing- and position-dependent effects of codon usage on 500 
protein production. 501 (A) Schematic outline of Flow-Seq experimental workflow. Stable HeLa and 502 HEK293 cell pools expressing 217 GFP variants were established using a 503 multiplex Flp-In integration approach, followed by FACS sorting, sequencing and 504 calculation of a fluorescence score for each variant (see Figure S4). 505 (B) Heatmap representation of Flow-Seq results. Rows represent normalised 506 read distributions of individual GFP variants across 8 fluorescence bins 507 (columns). The average difference between lowest and highest fluorescence bins 508 is around 100-fold. Data shown represents the average of 3 Flow-Seq 509 measurements for HeLa cells, the average of 2 Flow-Seq experiments for HeLa 510 with intron and 1 experiment for HEK293 cells. 511 (C) Pearson correlation matrix of experimental measurements obtained by Flow-512 Seq and sequence covariates. The colour of squares indicates the correlation 513 coefficient; crosses indicate non-significant correlations (p>0.05). 514 (D) Correlations between Flow-Seq measurements and GC3 content of 1st (nt 1-515 360) and 2nd (nt 361 - 720) halves of GFP sequences.  516 (E) Protein and mRNA measurements of translational fusion constructs between 517 GC-poor (30% GC3, Kpoor) and GC-rich (85% GC3, Krich) variants of mKate2 518 with a GC-rich (97% GC3, Grich) or GC-poor (33%, Gpoor) variants of GFP. Data 519 represents the mean of 3 replicates, +/- SEM. GFP protein RFU, mKate protein 520 RFU and RNA AU were defined as in Figure 2. 521 (F) Protein fluorescence measurements of 2 GC-poor GFP variants (GFP_154; 522 GC3=0.38 and GFP_403; GC3=0.37) expressed either as unspliced constructs, or 523 
with an intron placed within the 5’ UTR, the CDS or both. Data represents the 524 mean of 3 replicates, +/- SEM. All intron-containing constructs differ significantly 525 from their intronless counterparts (p<0.05, t-test). GFP protein RFU were 526 defined as (GFP fluorescence - background GFP fluorescence). See also Figures 527 S4 and S5. 528  529 
Figure 4. High GC content increases cytoplasmic localisation of mRNA. 530 (A) Stable HeLa pools expressing 217 GFP variants +/- intron were fractionated 531 into nuclear and cytoplasmic portions before RNA extraction. Specific markers of 532 
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subcellular compartments were quantified by qRT-PCR before amplicon-library 533 preparation. 534 (B) Relative cytoplasmic concentration (RCC) of unspliced and spliced GFP 535 variants. Data represents the mean of 2 replicates. ***p=2u10-6. 536 (C) Correlation between GC3 content and RCC for unspliced and spliced GFP 537 RNA. Data points represent the means of 2 replicates.  538 (D) Correlation between RCC scores of unspliced and spliced GFP (R2=0.1, 539 p=2.6u10-5). See also Figure S5. 540  541 
Figure 5. High GC content leads to increased ribosome association. 542 (A) (Left) A stable pool of HEK293 cells expressing 217 unspliced GFP variants 543 was subjected to polysome profiling using sucrose gradient centrifugation. 544 (Right, from top to bottom) UV absorbance profile, GFP mRNA abundance, 545 GAPDH mRNA abundance, ethidium bromide staining of gradient fractions. GFP 546 and GAPDH mRNA were quantified by qRT-PCR. 547 (B) RNA from collected fractions was combined into 4 pools (as indicated by 548 coloured boxes) before amplicon library preparation for high-throughput 549 sequencing: unbound ribonucleoprotein complexes (red), monosomes (yellow), 550 light polysomes (light green) and heavy polysomes (dark green). Resulting read 551 distributions (in %) for GFP variants are represented as heatmap. 552 (C) Correlation plot between mean ribosome density (left panel) and ribosome 553 association (right panel) of GFP variants and their corresponding GC3 content. 554 Triangles indicate outliers (Ribosome association values 24.89 (GC3=0.84) and 555 24.80 (GC3=0.90)). The ribosome density and ribosome association measures 556 were calculated as described in the methods section. 557  558 
Figure 6. Splicing-dependent codon usage shapes global gene expression. 559 Effects of GC4 content on the expression of unspliced (y-axis) and spliced (x-axis) 560 endogenous human genes, both on RNA and protein level. Each point 561 corresponds to the regression coefficient of an individual experiment (cell line 562 and/or biological replicate). Error bars indicate the standard error of these 563 regression coefficients. Surrounding ellipses indicate the 95% confidence 564 
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interval for 1,000 bootstraps of underlying data (see Methods, Figure S6 and 565 Table S1). The diagonal indicates x=y. See also Figure S6 and Table S1. 566 
 567 568 
 21 
STAR Methods 569 
 570 
Lead contact and materials availability 571 
 572 Further information and requests for resources and reagents should be directed 573 to, and will be fulfilled by, Grzegorz Kudla (gkudla@gmail.com). Plasmids 574 generated in this study will be distributed by Grzegorz Kudla. 575 
 576 
Experimental model and subject details 577 
 578 HeLa Flp-in T-Rex cells were obtained from the Andrew Jackson group, HEK293 579 Flp-in T-Rex cells were sourced from ThermoFisher, and HeLa cells were from 580 ATCC. 581 
 582 
Genes and plasmids 583 The library of 217 synonymous GFP variants used here consists of 138 variants 584 from an earlier study (Kudla et al., 2009), 59 new variants assembled using the 585 PCR-based method described in (Kudla et al., 2009), and 22 variants that were 586 designed in silico and ordered as synthetic gene fragments (gBlocks) from 587 Integrated DNA Technologies (IDT) (Mittal et al., 2018). Each of the 22 variants 588 was designed by setting a target GC3 content (between 25 and 95%) and 589 randomly replacing each codon with one of its synonymous codons, such that the 590 expected GC3 content at each codon position corresponded to the target GC3 591 content. For example, to design a GFP variant with GC3 content of 25%, each 592 glycine codon was replaced with one of the four synonymous glycine codons 593 with the following probabilities: GGA, 37.5%; GGC, 12.5%, GGG, 12.5%; GGT, 594 37.5%. We also generated 23 mKate2 sequences using an analogous procedure 595 and ordered the variants as gBlocks from IDT. All the genes were cloned into the 596 Gateway Entry vector pGK3 (Kudla et al., 2009). 597 
 598 
Construction of transient expression vectors 599 
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Plasmids used in transient transfection experiments are based on pCI-neo 600 (Promega), a CMV-driven mammalian expression vector that contains a chimeric 601 intron upstream of the multiple cloning site (MCS) within the 5’ UTR. This intron 602 
consists of the 5’ splice donor site from the first intron of the human beta-globin 603 
gene and the branch and 3’ splice acceptor site from the intron of 604 immunoglobulin gene heavy chain variable region (see pCI-neo vector technical 605 bulletin, Promega). This vector was adapted to be compatible with Gateway 606 recombination cloning by inserting the Gateway-destination cassette, RfA, using 607 the unique EcoRV and SmaI restriction sites present within the MCS of pCI-neo, 608 generating pCM2. This plasmid was then further modified by removing the 609 intron contained within the 5’ UTR by site-directed deletion mutagenesis using 610 Phusion-Taq (ThermoScientific) and primers ‘pCI_del_F’ and ‘pCI_del_R’ (see 611 Table S2 for list of all primers used), generating plasmid pCM1. 612 To be able to normalise spectrophotometric measurements from single GFP 613 transfection experiments, pCM1 and pCM2 were further modified to contain a 614 separate expression cassette driving the expression of a second fluorescent 615 reporter gene, mKate2. The mKate2 gene cassette from pmKate2-N (Evrogen) 616 was inserted via Gibson assembly cloning: First, the entire mKate2 expression 617 
cassette was amplified using primers ‘mKate2_gibs_F’ and ‘mKate2_gibs_R’ which 618 add overhangs homologous to the pCM insertion site. Next, pCM1 and pCM2 619 
were linearised by PCR using primers ‘pCI_gib_F’ and ‘pCI_gib_R’. All PCR 620 products were purified using the Qiagen PCR purification kit and fragments with 621 homologous sites recombined using the Gibson assembly cloning kit (NEB) 622 according to manufacturer’s instructions (NEB). Successful integration was 623 validated by Sanger sequencing. This generated plasmids pCM3 (-intron, 624 +mKate2) and pCM4 (+intron, +mKate2). 625  626 
Transient plasmid transfections for spectrofluorometric measurements 627 Plasmids for transient expression of fluorescent genes were transfected into 628 HeLa cells grown in 96-well plates. Per plasmid construct, 3 replicates were 629 tested by reverse transfection. Enough transfection mix for 4 wells was prepared 630 by diluting 280ng plasmid DNA in 40ul OptiMem (Gibco). 1ul Lipofectamine2000 631 (Invitrogen; 0.25ul per well) was diluted in 40ul OptiMem and incubated for 632 
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5min at room temperature. Both plasmid and Lipofectamine2000 dilutions were 633 then mixed (80ul total volume) and further incubated for 20-30min. 20ul of 634 transfection complex was then pipetted into each of 3 wells before adding 200ul 635 of HeLa cell suspension (45,000 cells/ml; 9,000 cells/well) in phenol red-free 636 DMEM (Biochrom, F0475). Media was exchanged 3-4h post-transfection to 637 reduce toxicity. Cells were then grown for a further 24h or 48h at 37C, 5% CO2. 638 After incubation, cells were lysed by removing media and adding 200ul of cell 639 lysis buffer (25mM Tris, pH 7.4, 150mM NaCl, 1% Triton X-100, 1mM EDTA, pH 640 8). Fluorescence readings were obtained using a Tecan Infinite M200pro 641 multimode plate reader. The plate was first incubated under gentle shaking for 642 15min followed by fluorescence measurements using the following settings: 643 Ex486nm/Em 515nm for GFP and Ex588nm/Em633nm for mKate2; reading 644 mode: bottom; number of reads: 10 per well; gain: optimal. 645 For data analysis, measurements of untransfected cells were subtracted as 646 background from all other wells. For comparability of different plates within a 647 set of experiments, the same 3 genes were transfected on every plate to account 648 for technical variability. In the screen of individual GFP variants (see Figure 2), 649 GFP measurements were divided by mKate2 measurements from same wells to 650 reduce noise caused by well-to-well variation in transfection efficiency, but 651 similar results were obtained without normalisation. 652 
 653 
Transient transfections and RNA extraction for qRT-PCR analysis 654 HeLa cells were reverse transfected in 12-well plates using 800ng plasmid DNA 655 and 2ul Lipofectamine 2000 (Invitrogen). DNA and Lipofectamine 2000 were 656 diluted in 100ul OptiMEM (Gibco) each, incubated for 5min, mixed and further 657 incubated for 20min. The transfection complex was then added to each well 658 before adding 105 HeLa cells. Cells were incubated for 24h at 37C, 5% CO2 659 before harvesting. Cells were then harvested by adding 1ml Trizol reagent (Life 660 
technologies). RNA was extracted according to manufacturer’s instructions. 661 Resulting RNA was further treated with DNAse I using the Turbo DNase kit 662 (Ambion) to remove any residual plasmid and genomic DNA.  663  664 
RT-PCR analysis 665 
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cDNA for qRT-PCR analysis was prepared using SuperScript III Reverse 666 
Transcriptase (Life technologies) according to the manufacturer’s 667 recommendations with 500ng total RNA as template and 500ng random 668 hexamers (Promega). All qRT-PCRs were carried out on a Roche LightCycler 480 669 using Roche LightCycler480 SYBR Green I Master Mix and 0.3uM gene-specific 670 primers. Samples were analysed in triplicate as 20ul reactions, using 2ul of 671 diluted cDNA. Cycling settings: DNA was first denatured for 5min at 95°C before 672 entering a cycle (50-60x) of denaturing for 10sec at 95°C, annealing for 7sec at 673 55-60°C (depending on primers used), extension for 10sec at 72°C and data 674 acquisition. DNA was then gradually heated up by 2.20 °C/s from 65 to 95°C for 675 5sec each and data continuously collected (Melting curve analysis). Data was 676 evaluated using the comparative Ct method (Livak and Schmittgen, 2001). RNA 677 measurements from transient transfection experiments were normalised to the 678 abundance of neomycin resistance marker (NeoR) RNA, which is expressed from 679 the same plasmid, to control for differences in transfection efficiency (primers 680 
‘Neo_F’ and ‘Neo_R’). PCRs performed on cDNA from stable Flp-in T-Rex cell lines 681 to measure splicing efficiency were performed on an Eppendcorf Mastercycler 682 nexus X2 in 20ul reaction volumes, using Accuprime Pfx (ThermoFisher) 683 
according to manufacturer’s instructions, using 0.3uM primers (intron-684 independent: pc5_5UTR_F &  pc5_3UTR_R1; intron specific: pc5_INT_F & 685 pc5_3UTR_R2). 686  687 
Subcellular fractionation 688 This protocol is based on the cellular fractionation protocol published by 689 (Gagnon et al., 2014) but includes a further clean-up step using a sucrose cushion 690 as described by (Zaghlool et al., 2013) and a second lysis step as described by 691 (Wang et al., 2006). Cell lysis and nuclear integrity was monitored throughout by 692 light microscopy following Trypan blue staining (Sigma). Cells were grown in 693 10cm plates for 24h to about 90% confluency. Cells were then washed with PBS 694 and trypsinised briefly using 1ml of 1xTrypsin/EDTA. After stopping the reaction 695 with 5ml DMEM, cells were transferred into 15ml falcon tubes and collected by 696 spinning at 100g for 5min. Resulting cell pellets were resuspended in 500ul ice-697 cold PBS, transferred into 1.5ml reaction tubes and spun at 500g for 5min, 4°C. 698 
 25 
The supernatant was discarded and cells resuspended in 250ul HLB (10mM Tris 699 (pH 7.5), 10mM NaCl, 3mM MgCl2, 0.5% (v/v) NP40, 10% (v/v) Glycerol, 0.32M 700 sucrose) containing 10% RNase inhibitors (RNasin Plus, Life Technologies) by 701 gently vortexing. Samples were then incubated on ice for 10min. After 702 incubation, samples were vortexed gently, spun at 1000g for 3min, 4°C, and 703 supernatants and pellets were processed separately as indicated in a) and b) 704 below. 705 a) Cytoplasmic extract: 706 The supernatant was carefully layered over 250ul of a 1.6M sucrose cushion and 707 spun at 21,000g for 5min. The supernatant was then transferred into a fresh 708 1.5ml tube and 1ml Trizol was added and mixed by vortexing. 709 b) Nuclear extract: 710 The pellets were washed 3 times with HLB containing RNase inhibitors by gently 711 pipetting up and down 10 times followed by a spin at 300g for 2min. After the 712 3rd wash, nuclei were resuspended in 250ul HLB and 25ul (10%) of detergent 713 mix (3.3% (wt/wt) sodium deoxycholate/6.6% (vol/vol) Tween 40) dropwise 714 added while vortexing slowly (600rpm). Nuclei were then incubated for 5min on 715 ice before spinning at 500g for 2min. The supernatant was discarded and pellets 716 resuspended in 1ml Trizol (Ambion) by vortexing. 10ul 0.5M EDTA are added to 717 each nuclear sample in Trizol and tubes heated to 65°C for 10min to disrupt very 718 strong Protein-RNA and DNA-RNA interactions. Tubes were then left to reach 719 room temperature and RNA was extracted following the manufacturer’s 720 instructions. 721 
 722 
Transcription inhibition assay 723 HeLa T-Rex Flp-in cell lines were grown to 80-90% confluency in 6 well for 24h 724 before treatment with 500nM Triptolide (Sigma). Cells were harvested at 725 indicated time points and RNA extracted using the Qiagen RNeasy kit (Qiagen, 726 74104). Control cells were treated with an equal volume of DMSO (drug carrier). 727 To assess transcript levels, qRT-PCR was performed as described above using 728 
primers ‘pc5_3UTR_F’ and ‘pc5_3UTR_R1’. GFP levels were normalised to levels 729 of 7SK, a RNA polymerase III-transcribed non-coding RNA, whose expression 730 levels are not affected by Triptolide treatment. Relative transcript levels of c-Myc 731 
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are shown as an example of a relatively unstable transcript, while levels of Gapdh 732 are shown as a stable transcript. Transcript half-lives (𝑡1/2) were calculated by 733 first fitting an exponential decay curve, 𝑦(𝑥) = 𝑎 × 𝑒𝑘𝑥 , through the data points 734 to obtain the decay constant k. The half-life is then calculated as  𝑡1/2 = ln(2) /𝑘 . 735  736 
Generation of stable Flp-in cell lines 737 We adopted a multiplex-Gateway integration method to create a pool of 217 GFP 738 plasmids which are compatible with the T-Rex Flp-in system (Invitrogen) for 739 creating stable, doxycycline-inducible cell lines, in which each variant is 740 expressed from the same genomic locus, allowing direct comparison of 741 expression levels.  742 pcDNA5/FRT/TO/DEST (Aleksandra Helwak, University of Edinburgh) contains 743 the Gateway-compatible attB destination cassette to allow the subcloning of 744 genes from any Gateway-entry vectors. This plasmid was further modified to 745 contain the same 5’ UTR intron sequence as in pCM4 used in transient 746 expression experiments using Gibson Assembly (NEB): the intronic sequence 747 
was amplified from pCM4 by PCR using primers ‘Gib_intr_F’ and ‘Gib_intr_R’ 748 using Q5 High-Fidelity Polymerase (NEB). The primers added 15nt overhangs 749 which are homologous to the ends of pcDNA5/FRT/TO/DEST when linearised 750 with AflII. The Gibson assembly reaction was performed as per manufacturer’s 751 instructions (NEB), generating pcDNA5/FRT/TO/DEST/INT. 752 217 individual GFP variants stored in Gateway-entry vector pGK3 were mixed 753 with a concentration of 0.06ng of each GFP variant. For each pcDNA5 destination 754 vector, a separate Gateway LR reaction was set-up in a total volume of 45ul using 755 500ng destination vector, 5ul LR Clonase enzyme mix, 38ul of the mixed 217 756 pGK3-GFP plasmids and TE (pH 8). The reactions were incubated at 25C 757 overnight followed by Proteinase K digest (5ul, LR Clonase kit) for 10min at 37C. 758 The total 50ul reaction mix was transformed into 2.5ml highly competent 759 DH5alpha in a 15ml Falcon tube by heat-shocking cells for 2min 30s at 42C, 760 followed by cooling on ice for 3min, before adding 10ml SOC medium and 761 incubating while shaking for 1h at 37C. After incubation, cells were spun down at 762 3000g for 3min and resulting bacterial pellets resuspended in 1ml fresh SOC. 763 10x100ul were plated onto L-Ampicillin agar plates and incubated overnight at 764 
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37C resulting in >800 colonies per plate. Bacterial colonies were scraped off the 765 plates and collected in a falcon tube. Plasmid DNA was extracted using a Qiagen 766 
Midiprep kit according to the manufacturer’s instructions, resulting in two 767 plasmid pools: pCDNA5/GFPpool and pcDNA5/INT/GFPpool. Both pools were 768 subjected to high-throughput sequencing to confirm the presence of different 769 GFP variants. 770 HeLa T-Rex Flp-in cells (gifted by the Andrew Jackson lab, The University of 771 Edinburgh) and HEK293 T-Rex Flp-in (Thermo Scientific) were grown to 80% 772 confluency in 6 well plates. For GFP plasmid pool transfections, 773 pCDNA5/GFPpool or pCDNA5/INT/GFPpool were mixed in a 9:1 ratio with the 774 Flp-recombinase expression plasmid pOG44 (Invitrogen) to give 2ug in total 775 (1.8ug pOG44 + 0.2ug pCDNA5) and diluted in OptiMEM (Gibco) to 100ul. 776 Transfections were performed with 9ul Lipofectamine2000 (Invitrogen) and 777 91ul OptiMEM per well by incubating 5min at room temperature before mixing 778 with plasmid DNA and a further 15min incubation. The transfection mix was 779 then added dropwise to the cells. Media were replaced with conditioned media 780 4h post-transfection. Cells were incubated for further 48h before chemical 781 selection to select for successful gene integration using 10ng/ul Blasticidin S 782 (ThermoFisher) and 400mg/ml (HeLa T-Rex Flp-in) or 100mg/ml (HEK293 T-783 Rex Flp-in) Hygromycin B (Life Technologies). Successful selection was 784 determined by monitoring cell death in untransfected cells. Chemically resistant 785 cells represent pools of cell lines expressing different GFP variants from the 786 same genomic locus. High-throughput sequencing of the GFP integration site 787 within each generated cell line pool confirmed the successful integration of all 788 variants.   789 HeLa T-Rex Flp-in and HEK293 T-Rex Flp-in cell lines expressing individual 790 intron-containing and intronless GFP variants were generated using the same 791 protocol. 792  793 
Flow-Seq: FACS sorting and genomic DNA extraction 794 80x15cm cell culture plates of HeLa T-Rex Flp-in GFP pool cells and 40x15cm cell 795 culture plates of HEK293 T-Rex Flp-in GFP pool cells were induced with 1ug/ml 796 Doxycyline (Sigma, D9891) in phenol red-free DMEM (Biochrom, F0475) 797 
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supplemented with 10% FCS (Sigma, F-7524) and 2mM L-Glutamine. After 24h 798 or 48h, cells were harvested by gentle trypsinisation and cells were sorted into 8 799 fluorescence bins using a BD FACS Aria II cell sorter. To define the range of GFP 800 positive signal, cells without stable GFP expression were used as negative 801 control. 80% of HeLa and 90% HEK293 GFP pool cells fell into the GFP-positive 802 range. Each fluorescence bin was chosen to comprise roughly 10% of the GFP-803 positive population. The bin spacing was kept the same for the sorting of HeLa 804 cell pools expressing unspliced and spliced GFP variants to allow direct 805 comparisons of the fluorescence profiles of individual variants. 806 About 107 cells per bin were collected in Polypropylene collection tubes (Falcon) 807 coated with 1% BSA/PBS, cushioned with 200ul 20%FBS/PBS. Cell suspensions 808 were decanted into 15ml tubes and cells collected by spinning 5min at 500g. The 809 supernatant was transferred into fresh 15ml tubes and precipitated using 2 810 volumes of 100% EtOH/0.1 volume Sodium Acetate (pH 5.3) and 10ul Glycoblue 811 (Ambion). Tubes were shaken vigorously for 10s before incubating at -20C for 812 15min, followed by spinning at 3000g for 20min. Resulting pellets were air-813 dried, resuspended in 1ml digest buffer (100mM Tris pH 8.5, 5mM EDTA, 0.2% 814 SDS, 200mM NaCl) and then combined with the respective cell pellet. 10ul RNAse 815 A (Qiagen, 70U) was added and samples gently rotated at 37C. After 1h, 1ul/ml 816 Proteinase K (20mg/ml, Roche) was added to the samples before rotating a 817 further 2h at 55C. Genomic DNA was purified 3 times by using 1 volume 818 Phenol:Chloroform:Isoamyl alcohol (PCI, 25:24:1, Sigma). After each addition of 819 PCI, samples were shaken vigorously for 10s before spinning at 3000g for 20min 820 (first extraction) or 5min (all following). The resulting bottom layers including 821 the interphase were removed before each PCI addition. After the last PCI 822 extraction, the upper layer was transferred into a fresh 15ml tube and 1 823 extraction performed using 1 volume chloroform:isoamyl alcohol (CI,24:1, 824 Sigma). After a 5min spin at 3000g, the upper layer was transferred into a fresh 825 15ml tube and DNA precipitated using EtOH/Sodium Acetate as before. After a 826 5min incubation on ice, DNA was collected by spinning for 30min at 3000g. The 827 resulting DNA pellets were washed 2 times with 75% EtOH before air-drying and 828 resuspending in 200ul Tris-EDTA (10mM). The quality of the extracted genomic 829 DNA was assessed on a 0.8% Agarose/TBE gel. 830 
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 831 
Polysome profiling 832 HEK293 Flp-in GFP pool cell lines were grown to 90% confluency on 15cm 833 dishes. Cells were treated for 20min with 100ug/ul Cycloheximide before 834 harvesting cells by removing media, washing with 2x ice-cold PBS followed by 835 scraping cells into 1ml PBS and transferring into 1.5ml tubes. Cells were pelleted 836 at 7000rpm, 4°C for 1min and resulting cell pellet carefully resuspended by 837 pipetting up and down in 250ul RSB (10x RSB: 200mM Tris (pH 7.5), 1M KCl, 838 100mM MgCl2) containing 1/40 RNasin (40U/ul, Promega), until no clumps 839 were visible. 250ul of polysome extraction buffer was then added (1ml 10x RSB 840 + 50ul NP-40 (Sigma) + 9ml H2O + 1 complete mini EDTA-free protease inhibitor 841 pill (Roche)) and lysate passed 5x through a 25G needle avoiding bubble 842 formation. The lysate was then incubated on ice for 10min before spinning 843 10min at 10,000g, 4°C. The supernatant was then transferred into a fresh 1.5ml 844 tube and the RNA concentration estimated by measuring the OD at 260nm. 845 Sucrose gradients (10–45%) containing 20 mM Tris, pH 7.5, 10 mM MgCl2, and 846 100 mM KCl were made using the BioComp gradient master. 100ug of Lysate 847 were loaded on sucrose gradients and spun at 41,000rpm for 2.5h in a Sorvall 848 centrifuge with a SW41Ti rotor. Following centrifugation, gradients were 849 fractionated using a BioComp gradient station model 153 (BioComp 23 850 Instruments, New Brunswick, Canada) by measuring cytosolic RNA at 254 nm 851 and collecting 18 fractions. 852 RNA from all fractions was precipitated using 1 volume of 100% EtOH and 1ul 853 Glycoblue (Ambion), before extracting RNA using the Trizol method (Life 854 Technologies). Equal volumes of RNA of each fraction was run on a 1.3% 855 Agarose/TBE gel to assess the quality of fractionation and RNA integrity. 856 Additionally, equal volumes of RNA of each fraction were used in cDNA synthesis 857 using SuperScript III (ThermoFisher) and 2uM gene-specific primers for GFP 858 
(‘pcDNA5-UTR_R’) and GAPDH (‘GAPDH_R’) followed by qRT-PCR analysis. For 859 high-throughput sequencing, total RNA from collected fractions was combined in 860 equal volumes into 4 pools (as indicated in Figure 5B; free ribonucleoprotein 861 (RNP) complexes, monosomes, light polysomes (2-4) and heavy polysomes (5+)) 862 before amplicon library preparation (as described below).  863 
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 864 
High-throughput library preparation and sequencing 865 Sequencing libraries were generated by PCR using primers specific for GFP 866 amplification (Table S2) which carry the required adaptor sequences for paired-867 end MiSeq sequencing, as well as 6nt indices for library multiplexing. Between 6-868 10ug of total genomic DNA were used in multiple PCR reactions (200ng per 50ul 869 reaction). All PCRs were performed using Accuprime Pfx (NEB) according to 870 
manufacturer’s recommendations using 0.4ul Accuprime Pfx Polymerase and 871 
0.3uM of each primer (‘PE_PCR_left’ and ‘S_indexX_right_PEPCR’). The cycling 872 conditions were as follows: Initial denaturation at 95C for 2min, followed by 30 873 cycles of denaturation at 95C for 15sec, annealing at 51C for 30sec, extension at 874 68C for 1min. The final extension was performed at 68C for 2min. After PCR, all 875 reactions of the same template were pooled and 1/3 of the reaction purified 876 
using the Qiagen PCR purification kit according to the manufacturer’s 877 instructions. DNA was eluted in 50ul H2O. Library size selection was performed 878 using the Invitrogen E-gel system (Clonewell gels, 0.8% agarose) followed by 879 Qiagen MinElute PCR purification. Correct fragment sizes were confirmed and 880 quantified using the Agilent Bioanalyzer 2100 system. 881 For library preparation of RNA samples, 500ng RNA was first converted into 882 cDNA using 2nmol GFP-specific primers (‘S_indexX_right_PEPCR’) using 883 
SuperScript III (Life technologies) according to manufacturer’s protocol, using 884 50C as extension temperature. Resulting cDNA was then treated with 1ul 885 RNaseH (NEB) for 20min at 37C, followed by heat inactivation at 65C for 5min. 886 Samples were diluted 1:2.5 before using 2ul as template in PCR for library 887 preparation. A minimum of 8x50ul PCR reactions were set up and pooled for 888 each sample before PCR purification, followed by E-gel purification as described 889 above. 890 High-throughput sequencing was conducted by Edinburgh Genomics (The 891 University of Edinburgh) and Imperial BRC Genomics facility (Imperial College 892 London) using the Illumina MiSeq platform (2x300nt paired-end reads). 893  894 
4sU labelling and separation of nascent RNA 895 
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GFP expression was induced for 24h using 1ug/ml Doxycyline (Sigma, D9891) at 896 80% confluency in 15cm cell culture dishes. To label nascent RNA, 4sU (Sigma, 897 T4509) was added to the media to a final concentration of 500 uM. Cells were 898 then further incubated at 37C, 5%CO2 for 20min. After incubation, cells were 899 harvested using 5ml Trizol reagent and RNA extracted following manufacturer’s 900 instructions using 1ml Chloroform and Phase Lock Gel Heavy tubes (15ml, 901 Eppendorf). Resulting RNA pellet was resuspended in 100ul RNAse-free water, 902 followed by a DNAse digest step using the TURBO DNA-free kit (Ambion) 903 
following manufacturer’s instructions. 904 Biotin labelling reactions were set up as following: 100ug RNA + 2ul Biotin-HPDP 905 (1mg/ml in DMF; Pierce, 21341) + 1ul 10x Biotinylation buffer (100mM Tris pH 906 7.4, 10mM EDTA) + H2O to 1ml. Reactions were then incubated for 1.5h at RT 907 with rotation. Unincorporated biotin-HPDP was removed by 2 x chloroform 908 extraction (1 volume) using Phase lock tubes (2ml, Eppendorf). The upper phase 909 was then transferred to a DNA lobind tube (Eppendorf, 0030108051) and RNA 910 precipitated using 1/10 reaction volume 5M NaCl and an equal reaction volume 911 of 100% Isopropanol. Resulting RNA pellet was washed with 70% Ethanol before 912 resuspending biotinylated RNA in 100ul RNAse-free water. 913 Streptavidin pull-down reactions were set up using 100ul biototinylated RNA 914 (up to 100ug RNA) + 100ul Streptavidin beads (Miltenyi, 130074101) and 915 reaction incubated for 15min at RT with gentle shaking. Streptavidin beads were 916 then isolated using uMACS columns (Miltenyi, 130074101) attached to a 917 magnetic stand. Columns were equilibrated with Washing buffer (WB; 100mM 918 Tris pH 7.5, 10mM EDTA, 1M NaCl, 0.1% Tween20) before adding Streptavidin 919 reaction mixtures to the column. Columns were then washed 3 times with WB 920 heated to 65C, followed by 3 times with WB at RT. RNA was then eluted using 921 100ul freshly prepared 100mM DTT, followed by purification using the Qiagen 922 RNeasy Minelute kit (Qiagen, 74204). RNA was eluted in 20ul RNAse-free water 923 and concentration determined using the Qubit RNA HS assay kit (Life 924 technologies, Q32852). cDNA synthesis was performed using equal amounts of 925 RNA across all samples using SuperScript III and qRT-PCRs performed as 926 
described in section ‘RT-PCR analysis’ using primers specific for the 3’ UTR 927 
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(‘pc5_3UTR_F’ + ‘pc5_3UTR_R1’) and intronic sequence (‘pCI-premRNA_F’ + ‘pCI-928 premRNA-R’). 929 
Quantification and Statistical analysis 930 
 931 
Analysis of GFP pool experiments 932 Raw sequencing files (database accession number PRJNA596086) were 933 demultiplexed by 6nt indices by the respective sequencing facility. To remove 934 the plasmid sequence, the second reads from paired-end sequencing were 935 trimmed using flexbar (-as ATGTGCAGGGCCGCGAATTCTTA -ao 4 -m 15 -u 30). 936 Reads were then mapped to the GFP library using bowtie2 (-X 750) and filtered 937 using samtools (-f 99).  938 For Flow-seq data, only variants with a minimum of 1000 reads across all 8 939 sequencing bins were used for further analysis. For each GFP variant, the 940 number of reads in each bin (n(i)) was multiplied by the respective bin index (i) 941 before taking the sum and dividing by the total number of reads across all bins: 942 
Fluorescence (variant) = ∑ 𝑖 ∗ 𝑛(𝑖)/8𝑖=1  ∑ 𝑛(𝑖)8𝑖=1  943 For cell fractionation experiments, only data with a minimum of 1000 reads 944 across both cytoplasmic and nuclear fractions was used to calculate the relative 945 
cytoplasmic concentration (‘RCC’) for each variant: 𝑅𝐶𝐶 =
𝑛(𝑐𝑦𝑡𝑜)
𝑛(𝑐𝑦𝑡𝑜)+𝑛(𝑛𝑢𝑐)
 946 For polysome profiling, only variants with a minimum of 1000 reads across all 4 947 sequencing bins were used for further analysis. To estimate ribosome density, 948 for each GFP variant, the number of reads in each bin (n(i)) was multiplied by the 949 respective bin index i (free RNA, i=1; monosomes, i=2; light polysomes, i=3; 950 heavy polysomes, i=4) before taking the sum and dividing by the total sum of 951 reads across all fractions:  952 
Ribosome density(variant) = ∑ 𝑖 ∗ 𝑛(𝑖)/4𝑖=1  ∑ 𝑛(𝑖)4𝑖=1  953 Ribosome association for each variant was calculated as the sum of reads (n) in 954 light polysomes, heavy polysomes and monosomal fractions, divided by the sum 955 of reads found in the free RNP fraction: 956 
Ribosome association(variant) = 957 
( 𝑛(𝑚𝑜𝑛𝑜𝑠𝑜𝑚𝑒𝑠) + 𝑛(𝑙𝑖𝑔ℎ𝑡 𝑝𝑜𝑙𝑦𝑠𝑜𝑚𝑒𝑠) + 𝑛(ℎ𝑒𝑎𝑣𝑦 𝑝𝑜𝑙𝑦𝑠𝑜𝑚𝑒𝑠)) 
𝑛(𝑓𝑟𝑒𝑒 𝑅𝑁𝑃𝑠)
 958 
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 959 
Definition of calculated sequence features 960 GC3: GC content in the third position of codons 961 CpG: number of CpG dinucleotides 962 dG: The minimum free energy of predicted mRNA secondary structure around 963 the start codon was calculated using the hybrid-ss-min program version 3.8 964 (default settings: NA = RNA, t = 37, [Na+] = 1, [Mg++] = 0, maxloop = 30, prefilter 965 = 2/2) in the 42-nt window (-4 to 38) as in (Kudla et al., 2009). 966 CAI: Codon Adaptation Index (H. sapiens) (Sharp and Li, 1987a) was calculated 967 using a reference list of highly expressed human genes collected from the EMBL-968 EBI expression atlas https://www.ebi.ac.uk/gxa. 969 tAI: tRNA adaptation index (dos Reis et al., 2004) 970 ARE: top score of ATTTA motif match in each sequence. 971 AT-stretch: number of times motif (AT){9} was identified in each sequence. 972 GC-stretch: number of times motif (GC){9} was identified in each sequence. 973 Poly_A: number of times the position-specific scoring matrix 974 ((47,3,0,50)(18,6,9,67)(53,12,12,23)(59,6,0,35)(70,6,6,18)) was identified in 975 each sequence. 976 SD_cryptic: number of times RSGTNNHT motif was identified in each sequence. 977 SD_PSSM: number of times the position-specific scoring matrix 978 ((60,13,13,14)(9,3,80,7)(0,0,100,0)(0,0,0,100)(53,3,42,3)(71,8,12,9)(7,6,81,6)(1979 6,17,21,46)) was identified in each sequence. 980  981 FIMO (http://meme-suite.org) was calculated to identify and count sequence 982 motifs. Open-source packages available for R were used for generating 983 correlation matrices (corrplot), heatmaps (ggplot2), boxplots 984 (graphics/ggplot2), The GC3 of all human coding sequences (assembly: 985 
GRCg38_hg38; only CDS exons) was calculated using R package ‘seqinr’.  986 
 987 
Analysis of GC content variation in the human genome 988 The GRCh38 sequence of the human genome, as well as the corresponding gene 989 annotations (Ensembl release 85), was retrieved from the Ensembl FTP site 990 (Zerbino et al., 2018). The full coding sequences (CDSs) of protein-coding genes 991 
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were extracted, filtered for quality and clustered into putative paralogous 992 families (see (Savisaar and Hurst, 2016) for full details). For all analyses, a 993 random member was picked from each putative paralogous cluster. In addition, 994 only one transcript isoform (the longest) was considered from each gene. Note 995 that exon rank was always counted from the first exon of the gene, even if it was 996 not coding. In Figure 1A, density was calculated using the ggplot2 997 geom_density() function. For Figure 1C, GC4 was averaged across all sites that 998 were at the same nucleotide distance to the TSS and within an exon of the same 999 rank. For the functional retrocopies analysis, the parent-retrocopy genes derived 1000 in (Parmley et al., 2007) were used. Pseudogenic retrocopies were retrieved 1001 from RetrogeneDB (Rosikiewicz et al., 2017). Retrocopy annotations were 1002 filtered to only leave human genes with a one-to-one ortholog in Macaca 1003 
mulatta. Next, only ortholog pairs where both the human and the macaque copy 1004 were annotated as not having an intact reading frame and where the human 1005 copy was annotated as KNOWN_PSEUDOGENE were retained. For the analyses 1006 reported in Figure S1, the functional retrocopies were also retrieved from 1007 RetrogeneDB, as we could not access genomic locations for the (Parmley et al., 1008 2007) set. The functional retrogenes were retrieved similarly to pseudogenes, 1009 except that both the human and the macaque copy were required to have an 1010 intact open reading frame and the human copy could not be annotated as 1011 
KNOWN_PSEUDOGENE. 1012 Python 3.4.2. was used for data processing and R 3.1.2 was used for statistics and 1013 plotting (R Development Core Team, 2005). 1014  1015 
Computation methods for analysis of endogenous gene expression 1016 
Data Collection 1017 See also Table S1 for summary of datasets used. 1018  1019 1. GC4 content was calculated for each protein-coding transcript annotated 1020 in GENCODE version 19 as the GC content of the third codon position 1021 across all fourfold-degenerate codons (CT*, GT*, TC*, CC*, AC*, GC*, GA*, 1022 CC*, GC*). The core promoter of each transcript is further defined as -300 1023 bp/+100 bp around the annotated TSS. 1024 
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2. The level of transcription initiation was quantified in K562 and Gm12878 1025 cells as the number of GRO-cap reads from the same strand which overlap 1026 the core promoter.  1027 3. Nuclear stability was assessed using CAGE data obtained in triplicate from 1028 Egfp, Mtr4 and Rrp40 knockdowns (GSE62047; (Andersson et al., 2014)). 1029 Similarly to the approach used for the GRO-cap data, we calculated the 1030 RPKM across core promoters for each library separately. The baseMean 1031 expression for each treatment was quantified using DESeq2, where 1032 promoters with no reads across any replicate were first removed from 1033 each comparison. Nuclear stability was then assessed as the fold-change 1034 between the Egfp and Mtr4 knockdown and cytoplasmic stability by the 1035 estimated fold-change between the Mtr4 and Rrp40 knockdowns. 1036 4. The level of the mature mRNA was quantified using RNA-seq libraries 1037 from whole cell samples (prepared as described elsewhere for HEK293 1038 cells and downloaded from 1039 http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncod1040 eCshlLongRnaSeq for Gm12878, HepG2, HeLa, Huvec and K562 cells). 1041 Reads were pseudoaligned against GENCODE transcript models using 1042 Kallisto, set with 100 bootstraps. All other parameters were left at their 1043 default. Transcript expressions were extracted as the estimated TPM 1044 (tags per million) values. 1045 5. The level of the mature mRNA in the nuclear and cytoplasmic fractions 1046 was quantified using Kallisto as previously. As transcript stability was 1047 similar in both fractions (linear regression coefficient 0.97, p < 2.2u10-16), 1048 nuclear export was determined as the fraction TPM from these two 1049 compartments which was present in the nuclear fraction.  1050 6. Ribosome-sequencing data from HEK293 (GSE94460) and HeLa 1051 (GSE79664) cells were used to quantify the level of mRNA translation in 1052 these two cells. Both of these measures were determined at the gene 1053 level, and so these observations were applied to all GENCODE transcripts 1054 
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annotated to these associated genes. These data were normalised to the 1055 mean mRNA expression in the relevant cell types (from step 4). 1056 7. Protein expression was assessed using mass-spectrometry data (Geiger et 1057 al., 2012) (Supp. Table 2) as the mean LFQ intensity across three 1058 replicates for each uniprot-annotated gene in each cell line for which data 1059 were available. Only data from genes where the UniProt ID is uniquely 1060 linked to a single transcript were considered in the analyses presented 1061 here.  1062 8. Protein stability was calculated as the level of the mature protein in 1063 HEK293 and HeLa cells (step 7) relative to the mean rate of mRNA 1064 translation in these cells (step 6). 1065 
Regression modelling 1066 A pseudocount of 0.0001 was added to each measurement of gene expression 1067 and, excluding the nuclear export data, these values were then log2-transformed 1068 to generate a normal distribution of expression for subsequent analysis. 1069 Transcripts with an expression value of 0 were removed from downstream 1070 analysis and the resulting distributions used for regression analysis are 1071 displayed in Figure S6. Transcripts were separated into unspliced and spliced, 1072 where splicing was defined as containing more than one exon in the GENCODE 1073 transcript model. Expression measurements were then linearly regressed 1074 against the GC4 content separately for each class of transcript and the 1075 coefficients along with their associated standard errors. These data were then 1076 bootstrapped by sampling with replacement and recalculating the regression 1077 coefficients for spliced and unspliced transcripts. The 95% confidence interval of 1078 these coefficients (discounting the standard error in these estimations) obtained 1079 by 1,000 samplings of this type was used to draw the ellipses shown in Figure 6. 1080 
Data and Software availability 1081 Raw sequencing files have been deposited in SRA and can be accessed under 1082 database accession number PRJNA596086. 1083  1084 
  1085 
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Bacterial and Virus Strains  
DH5alpha Life Technologies 18265017 
One Shot ccdB Survival 2 T1R Competent Cells ThermoFisher A10460 
   
   
Biological Samples   
   
   
   
   
   
Chemicals, Peptides, and Recombinant Proteins 
EcoRV NEB R0195 
SmaI NEB R0141 
LR Clonase II mix Invitrogen 11791100 
EcoRI NEB R0101 
BamHI NEB R0136 
T4 DNA Ligase NEB M0202 
Glycoblue Invitrogen AM9516 
Phusion Taq Polymerase Thermo Scientific F530S 
Accuprime Pfx Polymerase ThermoFisher 12344024 
RNeasy purification kit Qiagen 74104 
Trizol reagent Invitrogen 15596026 
Turbo DNA-free kit Invitrogen AM1907 
RNAse-free DNAse kit Qiagen 79254 
Opti-MEM reduced serum medium Gibco 31985062 
Phenol red-free DMEM Biochrom F0475 
Random hexamers Promega C1181 
SuperScript III Reverse Transcriptase Invitrogen 18080044 
Lightcycler480 SYBR Green I Master Mix Roche 04707516001 
Trypan blue Sigma-Aldrich T8154 
Trypsin solution Sigma-Aldrich T4174 
RNasin plus Promega N2611 
Proteinase K Roche 3115836001 
Blasticidin S Gibco R21001 
Hygromycin B Gibco 10687010 
Doxycyline Sigma-Aldrich D9891 
RNase A Qiagen 19101 
Phenol:Chlorofom:Isoamyl alcohol Sigma-Aldrich P2069 
 Cycloheximide   
4-Thiouridine Sigma-Aldrich T4509 
dCTP, [α-32P]- 3000Ci/mmol Perkin Elmer NEG013H250UC 
Biotin-HPDP Pierce 21341 
Dimethylformamide Pierce 20673 
Triptolide Sigma-Aldrich T3652 
Lipofectamine 2000 Invitrogen 11668019 
Critical Commercial Assays 
Gibson Assembly Cloning Kit NEB E5510S 
Qiaquick PCR purification kit Qiagen 28104 
MinElute PCR purification kit Qiagen 28004 
µMACS Streptavidin Kit Miltenyi Biotec 130-074-101 
DMEM LifeTechnologies 41965039 
Trypsin EDTA solution Sigma T4174 
   
Deposited Data 
Sequencing data SRA PRJNA596086 
   
   
   
   
Experimental Models: Cell Lines 
HEK293 T-REx Flp-in ThermoFisher R78007 
HeLa T-REx Flp-in Andrew Jackson Lab, 
MRC Human Genetics 
Unit, Edinburgh, UK. 
N/A 
   
   
   
Experimental Models: Organisms/Strains 
   
   
   
   
   
   
Oligonucleotides 
MiSeq library and sequencing primers This paper, Sigma Table S1 
Cloning primers This paper, Sigma Table S1 
(q)RT-PCR primers This paper, Sigma Table S1 
   
   
   
   
   
Recombinant DNA 
pGK3 (Gateway entry vector) Kudla et al., 2009 N/A 
 GFP variants Kudla et al., 2009, 
Mittal et al., 2018 
N/A 
mKate2 variants This paper N/A 
pCI-neo Promega E1841 
pBluescript-RfA Grzegorz Kudla, MRC 
Human Genetics Unit, 
Edinburgh, UK. 
N/A 
pmKate2-N Evrogen FP182 
pcDNA5/FRT/TO/DEST David Tollervey Lab, 
University of 
Edinburgh,Edinburgh, 
UK. 
N/A 
pOG44 (Flp-recombinase vector) ThermoFisher V600520 
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Python  Version 3.4.2 
R  Version 3.1.2 
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Other 
Infinite M200 Pro plate reader Tecan N/A 
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Antibodies 
Rabbit monoclonal anti-Snail Cell Signaling Technology Cat#3879S; RRID: 
AB_2255011 
Mouse monoclonal anti-Tubulin (clone DM1A) Sigma-Aldrich Cat#T9026; RRID: 
AB_477593 
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Bacterial and Virus Strains 
 pAAV-hSyn-DIO-hM3D(Gq)-mCherry Krashes et al., 2011 Addgene AAV5; 
44361-AAV5 
 
AAV5-EF1a-DIO-hChR2(H134R)-EYFP Hope Center Viral Vectors 
Core 
N/A 
Cowpox virus Brighton Red BEI Resources NR-88 
Zika-SMGC-1, GENBANK: KX266255 Isolated from patient 
(Wang et al., 2016) 
N/A 
Staphylococcus aureus ATCC ATCC 29213 
Streptococcus pyogenes: M1 serotype strain: strain 
SF370; M1 GAS 
ATCC ATCC 700294 
Biological Samples 
Healthy adult BA9 brain tissue University of Maryland 
Brain & Tissue Bank; 
http://medschool.umarylan
d.edu/btbank/ 
Cat#UMB1455 
Human hippocampal brain blocks New York Brain Bank http://nybb.hs.colum
bia.edu/ 
Patient-derived xenografts (PDX) Children's Oncology 
Group Cell Culture and 
Xenograft Repository 
http://cogcell.org/ 
Chemicals, Peptides, and Recombinant Proteins 
MK-2206 AKT inhibitor Selleck Chemicals S1078; CAS: 
1032350-13-2 
SB-505124 Sigma-Aldrich S4696; CAS: 
694433-59-5 (free 
base) 
Picrotoxin Sigma-Aldrich P1675; CAS: 124-
87-8 
Human TGF-β  R&D 240-B; GenPept: 
P01137 
Activated S6K1  Millipore Cat#14-486 
GST-BMAL1  Novus  Cat#H00000406-
P01 
Critical Commercial Assays 
EasyTag EXPRESS 35S Protein Labeling Kit Perkin-Elmer NEG772014MC  
CaspaseGlo 3/7 Promega G8090 
TruSeq ChIP Sample Prep Kit Illumina IP-202-1012 
Deposited Data 
Raw and analyzed data  This paper GEO: GSE63473 
B-RAF RBD (apo) structure This paper PDB: 5J17 
Human reference genome NCBI build 37, GRCh37 Genome Reference 
Consortium 
http://www.ncbi.nlm.
nih.gov/projects/gen
ome/assembly/grc/h
uman/ 
Nanog STILT inference This paper; Mendeley 
Data 
http://dx.doi.org/10.1
7632/wx6s4mj7s8.2 
Affinity-based mass spectrometry performed with 57 
genes 
This paper; and Mendeley 
Data 
Table S8; 
http://dx.doi.org/10.1
7632/5hvpvspw82.1 
Experimental Models: Cell Lines   
Hamster: CHO cells  ATCC CRL-11268 
 D. melanogaster: Cell line S2: S2-DRSC Laboratory of Norbert 
Perrimon 
FlyBase: 
FBtc0000181 
Human: Passage 40 H9 ES cells  MSKCC stem cell core 
facility 
N/A 
Human: HUES 8 hESC line (NIH approval number 
NIHhESC-09-0021) 
 
HSCI iPS Core hES Cell Line: 
HUES-8 
Experimental Models: Organisms/Strains  
C. elegans: Strain BC4011: srl-1(s2500) II; dpy-
18(e364) III; unc-46(e177)rol-3(s1040) V. 
Caenorhabditis Genetics 
Center 
WB Strain: BC4011; 
WormBase: 
WBVar00241916 
D. melanogaster:  RNAi of Sxl: y[1] sc[*] v[1]; 
P{TRiP.HMS00609}attP2 
Bloomington Drosophila 
Stock Center 
BDSC:34393; 
FlyBase: 
FBtp0064874 
S. cerevisiae:  Strain background: W303 ATCC ATTC: 208353 
Mouse: R6/2: B6CBA-Tg(HDexon1)62Gpb/3J The Jackson Laboratory JAX: 006494 
Mouse: OXTRfl/fl: B6.129(SJL)-Oxtrtm1.1Wsy/J The Jackson Laboratory RRID: 
IMSR_JAX:008471 
Zebrafish: Tg(Shha:GFP)t10:  t10Tg Neumann and Nuesslein-
Volhard, 2000 
ZFIN: ZDB-GENO-
060207-1 
Arabidopsis: 35S::PIF4-YFP, BZR1-CFP Wang et al., 2012 N/A 
Arabidopsis: JYB1021.2: 
pS24(AT5G58010)::cS24:GFP(-G):NOS #1 
NASC NASC ID: N70450 
Oligonucleotides 
siRNA targeting sequence: PIP5K I alpha #1: 
ACACAGUACUCAGUUGAUA 
 
This paper N/A 
Primers for XX, see Table SX This paper N/A 
Primer: GFP/YFP/CFP Forward: 
GCACGACTTCTTCAAGTCCGCCATGCC 
This paper N/A 
Morpholino: MO-pax2a 
GGTCTGCTTTGCAGTGAATATCCAT 
Gene Tools ZFIN: ZDB-
MRPHLNO-061106-
5 
ACTB (hs01060665_g1)  Life Technologies  Cat#4331182 
RNA sequence: hnRNPA1_ligand: 
UAGGGACUUAGGGUUCUCUCUAGGGACUUAG
GGUUCUCUCUAGGGA 
This paper 
 
N/A 
Recombinant DNA 
pLVX-Tight-Puro (TetOn) Clonetech Cat#632162 
Plasmid: GFP-Nito This paper N/A 
cDNA GH111110 Drosophila Genomics 
Resource Center 
DGRC:5666; 
FlyBase:FBcl013041
5 
AAV2/1-hsyn-GCaMP6- WPRE  
 
Chen et al., 2013 
 
N/A 
Mouse raptor: pLKO mouse shRNA 1 raptor Thoreen et al., 2009 Addgene Plasmid 
#21339 
Software and Algorithms 
ImageJ Schneider et al., 2012 https://imagej.nih.go
v/ij/ 
 Bowtie2 Langmead and Salzberg, 
2012 
http://bowtie-
bio.sourceforge.net/
bowtie2/index.shtml 
Samtools Li et al., 2009 http://samtools.sourc
eforge.net/ 
Weighted Maximal Information Component Analysis 
v0.9 
Rau et al., 2013 https://github.com/C
hristophRau/wMICA 
ICS algorithm This paper; Mendeley 
Data 
http://dx.doi.org/10.1
7632/5hvpvspw82.1 
Other 
Sequence data, analyses, and resources related to 
the ultra-deep sequencing of the AML31 tumor, 
relapse, and matched normal. 
This paper http://aml31.genome
.wustl.edu 
Resource website for the AML31 publication 
 
This paper https://github.com/ch
risamiller/aml31Supp
Site 
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Figure S1. GC variation amongst lncRNAs and parent-retrogene pairs and their downstream 
sequence, related to Figure 1.
Supplemental Text and Figures
Figure S1 (continued) (A) GC distribution of human long non-coding RNA genes, grouped by number of exons per gene. The Y axis indicates the proportion of genes within a given range of GC, calculated using the ggplot2 geom_density() function.(B) Mean GC content in non-coding exons, grouped by exon position (rank) and by number of exons per gene. (C) Mean GC within exons of rank 1 (black dots) or rank 2 (white dots) downstream of the transcription start site (TSS). (D) GC4 content distribu-tion across parent and retrogene pairs conserved between human and macaque. White violins indicate pairs for which retrocopies are classed as functional (p=0.26, n=31, two-tailed Wilcoxon signed-rank test), whereas grey violins correspond to pairs in which the retrocopy is classed as non-functional pseudogene (p < 2.2×10-16., n=1562, two-tailed Wilcoxon signed-rank test). For the human-macaque set, the difference in 
GC4 between parents and functional copies is in the expected direction but not signi�i-cant. (E) Violin plot showing GC content within a window between 2000 and 3000nt downstream from the stop codons of functional (white, p=9.27×10-4, n=31, two-tailed Wilcoxon signed-rank test) and non-functional (grey, p<2.2×10-16, n=1562, two-tailed Wilcoxon signed-rank test) parent-retrogene pairs conserved between human and macaque.
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Figure S2. GC content variation amongst endogenous genes and reporter libraries, related to 
Figure 2. (A) Libraries of reporter genes with random synonymous codon usage were designed to cover a broad range of GC3 content variation. Variants were expressed with and without a synthetic 5’ UTR intron. (B) GC3 content distribution amongst human consensus coding sequences (CDS; grey) in comparison to the GFP variant library used in this study (GFP lib; orange). Dashed lines indicate 
the ean GC͵ for each data setǤ ȋCǦȌ oessǦsoothed GC͵ pro�iles along the ʹʹ G	 ariants ȋCȌ 
and ʹ͵ ate ariants ȋȌ that were analsed b spectro�luoroetr ȋ	igure ʹȌǤ ȋȌ liding window analysis of GC content in 5’ UTRs of intronless expression cassettes utilised in this study. Blue: pCM3 
ȋtransient transfectionǡ no intronȌǢ redǣ pcͷȀ	ȀȀ ȋstable transfectionǡ no intronȌǤ ȋ	Ȍ As above, intron-containing expression cassettes. Blue: pCM4 (transient transfection, with intron); 
redǣ pcͷȀ	ȀȀȀ ȋstable transfectionǡ with intronȌǤ Gre shading indicates the position of the synthetic intron.
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Figure S3. Effect of GC content on expression of �luorescent reporter genes in stably 
transfected cell lines, related to Figure 2.
Figure S3 (continued). (A) RT-PCR using total RNA from HEK293 Flp-In cell lines stably expressing several variants of GFP with a broad GC3 range (GC3 range: 0.3 – 0.9) and containing the same 5’ UTR intron as used throughout this study. PCR was 
perfored using either Ǧspeci�ic priers that detect spliced as well as unspliced 
G	 transcripts ȋupper gelǡ labelled ǮǦspeci�icȌȌǡ or priers that exclusiel detect 
unspliced transcripts ȋlower gelǡ labelled ǮintronǦspeci�icǯȌǤ lasids containing the respective GFP expression cassettes, both with or without UTR intron, are shown as controls. (B-C) Flow cytometry measurements of GFP variants covering a broad range of GC3 variation in stably transfected HEK293 Flp-in (B) and HeLa Flp-in (C). (D-E) qRT-PCR measurements of nascent RNA isolated using 4sU labelling from 2 GC-poor (GC3=0.3 and 0.4) and 2 GC-rich (GC3=0.88 and 0.9) GFP variants, expressed as 
unspliced or spliced constructsǤ G	  leels were easured using ͵ǯ  speci�ic primers (D, full length transcripts) and intronic RNA levels (E, pre-mRNA). Data points represent the mean of 2 independent experiments, -/+ SD.
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Figure S4. Reproducibility of Flow-seq experiments in HeLa cells (unspliced GFP 
variants), related to Figure 3.
ȋǦȌ G	 	lowǦe �luorescence scores ȋ	Ȍǡ calculated as described in the ethods 
sectionǤ ȋȌ eǦseuencing of the sae apliconǦlibrarǤ ȋǦCȌ eplicate 	lowǦse 
experients perfored on the sae da ȋȌ or different das ȋCȌǤ ȋȌ 	lowǦe 
experients perfored on the sae pool of cellsǡ ʹ4h and 4ͺh after the induction of 
G	 expressionǤ ȋȌ Correlation between �luorescence easureents of ʹʹ G	 
ariants obtained in the ea G	 pool cell line b 	lowǦe ȋ axisȌ and in transientl 
transfected ea cells b spectro�luoroetr ȋ axisǡ data fro 	igure ʹȌǤ
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Figure Sͷ. ositionǦspeci�ic effects of GC content on expression, related to Figures 3 and Ͷ.(A) Sliding window analysis of GC3 content in selected GFP variants used in the pooled amplicon sequencing experiments. (B) Correlations between the GC3 content in the 1st (nt 1-360) and 2nd (nt 361-720) halves of GFP variants and their relative cytoplasmic mRNA concentrations (RCC).
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Figure S6. Distribution of RNA and protein expression data used in regression modelling, 
related to Figure 6.
Figure S6 (continued) Human RNA and protein expression data were extracted from 
arious databasesǡ �iltered and noralied as described in able ͳ and  ethodsǤ 
he histogras show the distributions of preprocessed expression easureentsǤ
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Table S1. Sources of human gene expression data, related to Figure 6. The cellular process 
to be uanti�ied is indicated aboe the tableǡ and the experiental techniues and data sources 
are indicated belowǤ ach dot indicates an experiental replicate easureentǤ
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